K121905 is an FDA 510(k) clearance for the ALERE PBP2A TEST. Classified as System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies (product code MYI), Class II - Special Controls.
Submitted by Alere Scarborough, Inc. (Scarborough, US). The FDA issued a Cleared decision on July 26, 2012 after a review of 27 days - a notably fast clearance cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.